JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
100 hedge funds and large institutions have $221M invested in Jounce Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 30 increasing their positions, 24 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
+23
Holders Change %
+29.87%
% of All Funds
1.97%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
32
Increased
30
Reduced
24
Closed
8
Calls
$876K
Puts
$839K
Net Calls
+$37K
Net Calls Change
-$20K
Top Buyers
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
$0 |
| 2 |
JPMorgan Chase & Co
New York
|
$1.53M |
| 3 |
D.E. Shaw & Co
New York
|
$298K |
| 4 |
Millennium Management
New York
|
$561K |
| 5 |
SO
STRS Ohio
Columbus,
Ohio
|
$593K |
